Purchase Order HHSN272201200764P
- Not listed
- This $4,881 firm fixed-price purchase order was awarded to Miltenyi Biotec, Inc., a global biotechnology company that provides specialized scientific instruments, reagents, and services to support biomedical research and cell therapy development. The award is for the delivery of lab equipment to the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH). Miltenyi Biotec has extensive experience as a prime contractor for federal...
- This is a $8,379.00 firm fixed price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID) to Miltenyi Biotec, Inc., a global biotechnology company, for the supply of biomaterials. The award is not designated as a set-aside contract. Miltenyi Biotec is a prime contractor that frequently supports federal biomedical research programs with its specialized cell separation, analysis, and processing technologies, including flow cytometers, cell sorters, and...
- This is a firm fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID) to Miltenyi Biotec, Inc., a global biotechnology company that provides specialized scientific instruments, reagents, and services for biomedical research and cell therapy development. The contract is valued at $4,058.00 and provides for the delivery of Miltenyi Biotec's dissociation kits, buffers, and antibodies. This award is not associated with a set-aside designation....
- This is a fixed-price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Miltenyi Biotec, Inc., a global biotechnology company. The $4,250 contract is for the supply of specialized scientific instruments, reagents, and services to support biomedical research, cell therapy development, and clinical translation. Miltenyi Biotec has significant experience as a prime contractor for various...
- This is a $3,641 firm fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID) to Miltenyi Biotec, Inc., a global biotechnology company that specializes in cell separation, analysis, and processing technologies. The contract does not have a set-aside designation. The award supports NIAID's biomedical research programs, particularly in areas such as cancer, immunology, and infectious diseases. Key deliverables include the supply of FDA-approved,...
- This is a $14,781 fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a division of the National Institutes of Health (NIH), to Miltenyi Biotec, Inc. The contract is for the supply of specialized biotechnology products and services, including cell separation and analysis equipment, reagents, and consumables. Miltenyi Biotec is a global biotechnology company that frequently provides equipment and supplies to federal agencies like the NIH,...
- This is a firm fixed-price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Miltenyi Biotec, Inc. The $12,810 contract provides for the delivery of specialized scientific instruments, reagents, and services to support biomedical research, cell therapy development, and clinical translation. Key deliverables include flow cytometers, cell sorters, tissue dissociators, automated cell...
- This is a $4,250 fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID) to Miltenyi Biotec, Inc., a foreign-owned, for-profit manufacturer of biotechnology products. The contract is not set aside and runs through May 2011. Miltenyi Biotec provides specialized scientific instruments, reagents, and services to support biomedical research, particularly in areas such as cancer, immunology, and infectious diseases. Key deliverables under this award...
- The U.S. National Institute of Allergy and Infectious Diseases (NIAID) awarded a $5,950 firm-fixed-price purchase order to Miltenyi Biotec, Inc. for maintenance services. The order was placed on December 5, 2014 with a completion date of December 14, 2015. Miltenyi Biotec is a global biotechnology company that provides specialized scientific instruments, reagents, and services to government agencies. This order is not associated with a set-aside program. Additionally, Miltenyi Biotec holds a...
- This is a $17,976 firm fixed price purchase order awarded to Miltenyi Biotec, Inc. by the National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH) for laboratory equipment and supplies. The contract is not set aside. Miltenyi Biotec is a global biotechnology company that specializes in cell separation, analysis, and processing technologies. Under this contract, the company will provide a variety of products and services to support biomedical...
This is a $4,250 firm-fixed-price purchase order contract between the National Institute of Allergy and Infectious Diseases (NIAID) and Miltenyi Biotec, Inc., a global biotechnology company that provides specialized scientific instruments, reagents, and services. The contract is not set aside and supports NIAID's biomedical research programs, particularly in areas such as cancer, immunology, and infectious diseases. Miltenyi Biotec has extensive experience as a prime contractor for numerous federal agencies, including the NIH, VA, FDA, DoD, CDC, and USDA, providing a diverse array of goods and services such as specialized laboratory equipment, reagents, and technical support. Additionally, Miltenyi Biotec holds a $2.3 million single-award indefinite delivery contract with the NIH Clinical Center, which provides for the supply of proprietary CliniMACS cell isolation reagents and consumables through September 2024, with options to extend to 2027.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.3k | 8/22/12 |